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Abstract	
	
Background	
	
Accurate	assessment	of	steatosis	in	procured	livers	is	crucial	to	reduce	the	poor	outcome	
associated	with	high-grade	steatosis	and	to	optimize	the	utilization	of	donor	grafts.	Clinical	
examination	and	digital	image	analysis	(DIA)	have	been	used	for	steatosis	evaluation,	but	the	
validity	of	these	methods	is	debated.	This	study	aimed	to	compare	these	methods	with	standard	
histology	for	assessment	of	steatosis	severity	in	human	livers	and	to	evaluate	a	revised	
classification	system	for	automated	fat	measurement.	
	
Methods	
	
Clinical	assessment	of	liver	steatosis	at	time	of	retrieval	and	automated	measurement	were	
compared	with	standard	histology	in	paraffinized	and	hematoxylin	and	eosin–stained	slides,	
using	a	4-grade	scale	for	ordinal	data	and	percentages	for	numerical	values.	
	
Results	
	
Analysis	of	42	human	livers	that	were	retrieved	but	not	transplanted	showed	that	clinical	
examination	was	not	reliable	for	assigning	steatosis	grades	(κw,	0.12;	95%	CI,	−0.06	to	0.30),	
overestimated	steatosis	severity,	and	had	an	accuracy	of	67%	for	discriminating	low-	and	high-
grade	steatosis.	Digital	image	analysis	had	a	substantial	agreement	on	absolute	fat	percentage	
(intraclass	correlation	coefficient,	0.76;	95%	CI,	0.63–0.84)	and	steatosis	grades	(κw,	0.70;	95%	
CI,	0.57–0.82),	with	88%	accuracy	using	the	revised	classification	system.	
	
Conclusions	
	
Clinical	assessment	of	steatosis	is	inaccurate,	and	relying	on	this	method	alone	could	result	in	
unnecessary	discard	of	livers.	Digital	image	analysis	is	feasible	with	higher	accuracy	and	
reliability,	but	further	clinical	studies	are	required	to	evaluate	its	clinical	validity.	
	
	 	
Background	
	
Hepatic	steatosis	is	found	in	up	to	30%	of	deceased	donor	livers	[1–3].	Accurate	assessment	of	
steatosis	severity	is	crucial	because	of	the	significant	association	between	high-grade	steatosis	
and	poor	graft	outcomes	[4,5]	and	to	optimize	the	utilization	of	donor	grafts.	The	retrieving	
surgeon	must	visually	assess	steatosis	of	the	donor	organ	in	real	time,	but	this	method	is	highly	
subjective	and	inaccurate	[6],	and	studies	comparing	surgical	evaluation	with	microscopic	
examination	are	limited	and	controversial	[7–9].	
	
The	current	criterion	standard	for	steatosis	assessment	is	based	on	a	semiquantitative	visual	
estimation	of	hematoxylin	and	eosin	(H&E)–stained	parenchymal	sections	at	low-to-medium	
power	magnification	by	the	pathologist	[10].	Unfortunately,	the	reproducibility	of	this	method	
has	also	been	a	matter	of	debate	[10–16].	Alternative	microscopic	techniques	such	as	digital	
image	analysis	(DIA)	and	stereological	point	counting	are	less	commonly	used	despite	showing	
higher	reproducibility	and	accuracy	[10,17,18].	One	possible	reason	for	the	limited	utilization	of	
DIA	is	the	measurement	discrepancy	between	this	method	and	visual	estimation;	fat	percentages	
obtained	by	standard	histology	are	1.5-	to	4-fold	higher	than	results	obtained	by	DIA	
[10,11,14,15,17,19,22],	which	requires	standardization	of	DIA	results	to	match	the	criterion	
standard	[10,17,19].	
	
This	study	aimed	to	compare	surgical	examination	and	DIA	with	the	standard	H&E	assessment	
by	the	pathologist	for	evaluation	of	steatosis	severity	in	human	livers	and	to	evaluate	a	revised	
classification	system	for	automated	fat	measurement.	
	
Materials	and	Methods	
	
Ethical	approval	for	this	study	was	granted	by	the	North	London	Regional	Ethics	Committee	3	
(reference	no.	10/H0709/70).	A	total	of	42	livers	were	procured	for	transplant	by	different	organ	
retrieval	teams	across	the	United	Kingdom	but	found	to	be	unsuitable	for	transplant	were	
analyzed.	Livers	were	refused	because	of	a	combination	of	donor	and	graft	factors;	60%	of	the	
organs	originated	from	donors	after	circulatory	death	and	were	associated	with	steatosis,	
fibrosis,	poor	liver	function,	and	long	ischemia	times.	Appropriate	consent	was	obtained	from	the	
next	of	kin,	and	the	livers	were	retrieved,	flushed,	and	transported	in	preservation	solution	on	ice	
as	with	standard	United	Kingdom	practice	for	clinical	use	[23].	
	
Biopsy	Collection	and	Processing	
	
On	arrival	at	the	research	laboratory,	a	wedge	biopsy	(>	1.5	cm2)	was	obtained	from	liver	
segments	4	and	7	(2	specimens	per	liver).	The	number	of	specimens	was	based	on	
recommendations	that	2	biopsies	from	different	liver	segments	are	required	for	suspicious	liver	
pathology	because	of	intraliver	pathology	variation	[24].	Biopsy	specimens	were	fixed	in	
formaldehyde	and	paraffinized.	One	4-μm	section	was	obtained	from	each	paraffinized	block	and	
stained	with	H&E	before	pathologist	and	DIA	assessment	(2	slides	per	liver).	
	
Standard	Histologic	Assessment	(the	Criterion	Standard)	
	
Two	experienced	pathologists	(TVL	and	JW)	estimated	steatosis	severity	in	whole	liver	slides	
using	light	microscopy	(Nikon	Eclipse	E600	microscope,	Nikon	UK	Ltd,	Kingston,	United	
Kingdom)	at	10×	objective	magnification.	
	
This	assessment	yielded	the	estimated	percentage	of	liver	parenchyma	occupied	by	fat,	or	
estimated	fat	proportionate	area	(eFPA),	which	was	expressed	in	percentages	on	a	scale	of	0%	to	
100%	and	graded	semiquantitatively	according	to	the	commonly	used	nonalcoholic	fatty	liver	
disease	activity	score	[25]	as	normal	(none)	<	5%,	mild	5%	to	33%,	moderate	>	33%	to	66%,	and	
severe	>	66%.	Slides	from	the	2	liver	segments	were	compared	for	intersite	variation	within	each	
liver.	The	2	pathologists	were	blinded	to	each	other	and	the	intraoperative	grading	and	DIA	
results.	
	
Clinical	Assessment	and	Grading	System	
	
During	retrieval,	surgeons	routinely	graded	steatosis	as	none	(0),	mild	(1),	moderate	(2),	or	
severe	(3)	steatosis.	Results	were	collected	retrospectively	from	organ	retrieval	forms,	which	
accompany	all	procured	organs	and	record	donor	information,	ischemia	times,	anatomic	
characteristics,	preservation	solution	used,	and	steatosis	severity.	
	
Digital	Image	Analysis	
	
The	measured	fat	proportionate	area	(mFPA)	was	calculated	using	DIA	in	the	same	slides	
evaluated	by	the	2	pathologists.	Techniques	for	image	capturing,	artifacts	exclusion,	and	binary	
segmentation	were	adapted	from	Hall	et	al	[10,14].	At	10×	objective	magnification,	3	random	and	
nonoverlapping	microscopic	fields	were	selected	from	each	slide	and	captured	using	Nikon	DS-
Fi1	camera	(Nikon	UK	Ltd).	Results	from	the	3	microscopic	fields	were	averaged	to	obtain	whole	
slide	mFPA,	which	was	expressed	in	percentages	on	a	scale	of	0%	to	100%.	Because	of	the	known	
discrepancy	between	DIA-measured	and	pathologist-estimated	fat	percentage	area,	we	used	a	
revised	mFPA	classification	system	based	on	findings	by	Marsman	[17]	and	Hall	[14].	We	
hypothesized	an	additional	cutoff	point	for	normal	(nonsteatotic)	livers,	which	was	not	suggested	
by	the	latter	researchers	to	conform	to	the	4-grade	scale	used	by	pathologists.	Accordingly,	
steatosis	grades	corresponding	to	mFPA	percentages	were	normal	<	2%,	mild	2%	to	10%,	
moderate	>	10%	to	25%,	and	severe	>	25%.	Slides	from	the	2	liver	segments	were	compared	for	
intersite	variation	within	each	liver.	The	operator	(HA)	was	blinded	to	the	results	of	the	other	2	
assessment	methods.	
	
Data	Analysis	
	
Data	were	analyzed	using	SPSS	Statistics	for	Macintosh,	Version	20.0	(IBM,	Armonk,	NY,	United	
States).	Interrater	reliability	was	assessed	using	intraclass	correlation	coefficient	(ICC),	Cohen’s	
kappa	(κ),	and	weighted	kappa	(κw)	for	continuous,	binomial,	and	ordinal	variables,	respectively,	
and	reliability	was	interpreted	according	to	Landis	and	Koch	[26].	Sensitivity,	specificity,	and	
overall	accuracy	were	calculated	as	measures	of	diagnostic	accuracy	after	dichotomizing	the	
livers	into	low-	and	high-grade	steatosis	(≤	mild	steatosis	and	≥	moderate	steatosis,	
respectively).	Mann-Whitney	test	was	used	to	analyze	intersite	variability.	The	level	of	
significance	was	set	at	P	<	0.05.	
	
Results	
	
Standard	H&E	Histologic	Assessment	
	
In	total,	84	slides	from	42	livers	were	analyzed.	The	agreement	between	the	2	pathologists	was	
almost	perfect	on	absolute	eFPA	scores	(ICC,	0.90;	95%	CI,	0.81–0.94)	and	substantial	on	grading	
steatosis	(κw,	0.75;	95%	CI,	0.60–0.90).	The	average	eFPA	was	12%	(SD,	16%;	range,	0%–58%),	
and	livers	were	classified	according	to	their	steatosis	grades	as	normal	(n	=	20),	mild	(n	=	17),	
moderate	(n	=	5),	and	severe	(n	=	0)	(Fig	1).	There	was	no	difference	in	steatosis	severity	
between	liver	segments	4	and	7	(P	=	0.6).	
	
	
	
Fig	1	Bar	chart	showing	the	number	of	livers	per	assessment	method	and	steatosis	grade	(n	=	42).	The	number	of	livers	
graded	by	surgeons	is	underrepresented	(n	=	36),	as	6	livers	were	classified	as	borderline	steatosis	(1	mild-moderate	and	
5	moderate-severe	steatosis).	DIA,	digital	image	analysis.	
	
	
Of	42	livers,	10	had	macrosteatosis	and	grade	1	to	2	neutrophil	infiltration	(perivenular	and	
midzonal,	respectively)	but	no	ballooning	or	perivenular	“chicken-wire”	fibrosis.	Consequently,	
none	of	the	livers	were	diagnosed	with	steatohepatitis	[25,27,28].	Neutrophil	infiltration	was	
most	likely	due	to	ischemia-reperfusion	injury	or	proinflammatory	processes	in	brain-dead	
donors	[29–32].	None	of	the	livers	were	reported	to	have	microvascular	abnormalities.	
	
Clinical	Assessment	
	
Of	42	livers,	6	were	reported	to	have	borderline	steatosis	according	to	retrieval	surgeons	(1	
mild-moderate	and	5	moderate-severe	steatosis).	Steatosis	was	graded	in	the	remaining	livers	as	
normal	(n	=	11),	mild	(n	=	11),	moderate	(n	=	12),	and	severe	(n	=	2)	(Fig	1).	
	
Agreement	between	surgeons	and	pathologists	on	assigning	steatosis	grades	omitted	6	livers	
that	did	not	adhere	to	the	4-grade	scale.	The	agreement	for	the	remaining	livers	(n	=	36)	was	
slight	and	no	better	than	chance	(κw,	0.12;	95%	CI,	–0.06	to	0.30).	The	2	livers	reported	by	
surgeons	to	have	severe	steatosis	were	graded	as	mild	and	moderate	by	pathologists.	
	
When	livers	were	dichotomized	into	low-	or	high-grade	steatosis,	surgeons	classified	23	livers	as	
low-grade	steatosis	and	19	livers	as	high-grade	steatosis	(n	=	42	livers),	and	there	was	a	fair	
agreement	beyond	chance	for	discriminating	low-	and	high-grade	steatosis	(κ,	0.28;	95%	CI,	
0.07–0.49).	Sensitivity,	specificity,	and	diagnostic	accuracy	of	clinical	assessment	were	100%,	
62%,	and	67%,	respectively.	
	
Digital	Image	Analysis	Assessment	
	
A	total	of	84	slides	from	42	livers	were	analyzed	using	DIA.	The	average	mFPA	was	6%	(SD,	7%;	
range,	0%–29%).	Absolute	mFPA	scores	were	lower	than	absolute	eFPA	(1.5-fold	higher	for	eFPA	
on	average),	and	this	discrepancy	became	more	evident	as	steatosis	severity	increased	(Fig	2).	
The	agreement	between	DIA	and	pathologists	on	absolute	fat	percentage	was	substantial	(ICC,	
0.76;	95%	CI,	0.63–0.84).	
	
	
Fig	2	Scatterplot	of	estimated	fat	proportionate	area	(eFPA)	and	measured	fat	proportionate	area	(mFPA).	There	is	a	
strong	overall	agreement	(ICC,	0.76;	95%	CI,	0.63–0.84).	The	agreement	was	stronger	at	lower	steatosis	levels,	and	mFPA	
scores	were	generally	lower	than	eFPA	scores	as	steatosis	severity	increased.	eFPA,	estimated	fat	proportionate	area;	ICC,	
intraclass	correlation	coefficient;	mFPA,	measured	fat	proportionate	area.	
	
	
According	to	the	revised	mFPA	classification	system,	livers	were	graded	as	normal	(n	=	13),	mild	
(n	=	19),	moderate	(n	=	8),	and	severe	(n	=	2)	(Fig	1).	The	agreement	between	DIA	and	
pathologists	was	substantial	on	assigning	steatosis	grades	(κw,	0.70;	95%	CI,	0.57–0.82).	The	2	
livers	classified	by	DIA	as	severe	steatosis	were	graded	as	moderate	by	pathologists	and	were	
different	to	the	2	severely	steatotic	livers	as	per	clinical	examination.	
	
Sensitivity,	specificity,	and	diagnostic	accuracy	of	DIA	were	100%,	87%,	and	88%,	respectively.	
Finally,	there	was	no	difference	in	steatosis	severity	between	liver	segments	4	and	7	(P	=	0.8).	
	
Discussion	
	
This	is	the	first	study	to	compare	quantitative	liver	steatosis	assessment	by	standard	H&E	
histology	with	retrieval	surgeons	and	the	newer	technique	of	DIA.	Additionally,	we	evaluated	a	
revised	steatosis	grading	system	for	automated	fat	measurement	as	an	objective	means	of	
steatosis	assessment.	
	
Hepatic	steatosis	is	a	common	finding	in	deceased	donor	livers	[1–3].	Based	on	United	Kingdom	
transplant	figures	between	2006	and	2016,	steatosis	was	the	most	common	reason	for	
nonutilization	(39%)	in	deceased	donor	livers	that	were	retrieved	but	not	transplanted	[33].	
Because	of	the	prevalence	of	steatosis	and	its	association	with	poor	outcome	in	transplanted	
livers,	accurate	assessment	is	crucial	to	maximize	the	utilization	of	livers	and	reduce	the	
mortality	and	morbidity	associated	with	high-grade	steatosis.	
	
Subjective	assessment	of	liver	specimens	by	the	pathologist	is	the	criterion	standard	for	
evaluating	liver	steatosis.	This	method	has	been	criticized	for	poor	interpathologist	
reproducibility	[11],	but	our	results	show	excellent	interpathologist	agreement	in	estimating	fat	
percentage	area	and	assigning	steatosis	grades,	similar	to	other	reports	[10,14,15,18,25].	It	is	
possible	that	the	poor	reliability	reported	previously	is	related	to	different	steatosis	definitions	
and	cutoff	values	as	well	as	varying	levels	of	experience.	
	
Macroscopic	assessment	by	the	retrieving	surgeon	is	highly	subjective	and	inaccurate	[6],	and	
studies	have	reported	both	underestimation	[34]	and	overestimation	[7,8]	of	steatosis	by	
surgeons.	A	survey	of	surgical	practice	in	the	United	Kingdom	and	United	States	indicated	that	
38%	of	UK	surgeons	and	47%	of	US	surgeons	performed	biopsies	if	the	liver	looked	
macroscopically	steatotic,	while	50%	of	UK	surgeons	did	not	incorporate	microscopic	
assessment	in	their	practice	at	all	[6].	In	our	research,	clinical	evaluation	was	inaccurate	and	
overestimated	steatosis	severity	compared	with	the	criterion	standard,	which	was	also	reflected	
by	the	high	percentage	of	false	positives	in	this	cohort	(38%).	Given	the	shortage	in	donor	livers,	
this	risks	unnecessary	discard	of	potentially	transplantable	grafts	based	on	clinical	assessment	
alone.	Clinical	evaluation	should	be	viewed	as	a	screening	test	and	should	not	be	used	exclusively	
to	discard	grafts.	When	significant	steatosis	is	suspected	clinically,	microscopic	examination	
before	transplant	is	recommended,	as	per	UK	transplantation	guidelines	[23].	Surgical	
assessment	remains	vital	for	identifying	other	pathologies	such	as	poor	organ	perfusion	or	
mottling,	fibrosis,	focal	lesions,	and	vascular	abnormalities.	
	
Although	it	is	common	practice	for	surgeons	to	visually	classify	livers	according	to	a	4-tier	
grading	system,	this	scale	was	originally	adapted	from	clinical	studies	demonstrating	a	
significant	association	between	poor	graft	outcome	and	steatosis	severity	based	on	microscopic	
steatosis	assessment	[4,5].	To	demand	surgeons	adhere	to	a	4-graded	pathologic	scale	is	not	
supported	by	high-level	evidence	and	might	be	counterproductive,	as	demonstrated	here	by	the	
poor	agreement	between	surgeons	and	pathologists	on	assigning	steatosis	grades.	It	is	more	
feasible	for	surgeons	to	classify	retrieved	livers	into	low-grade	and	high-grade	steatosis,	which	
emphasizes	the	role	of	clinical	evaluation	as	a	screening	test	that	should	ideally	be	followed	by	a	
more	objective	diagnostic	investigation.	It	might	be	useful	to	include	real-time	images	of	the	
organ	before	and	after	perfusion	to	enhance	the	perception	of	steatosis	severity	among	clinicians,	
although	standardization	of	image	quality	and	light	source	stability	is	required	to	ensure	
reproducibility	of	the	results.	
	
Automated	measurement	of	steatosis	using	DIA	has	previously	shown	higher	reproducibility	and	
accuracy	compared	with	standard	H&E	examination	[10,14,17,19].	It	is	likely	that	the	lack	of	
high-level	clinical	evidence	for	automated	measurement	and	confusion	originating	from	the	
discrepancy	between	measured	and	estimated	fat	percentages	have	restricted	the	widespread	
application	of	this	method.	
	
In	this	study,	absolute	eFPA	scores	were	higher	than	mFPA	measurements,	similar	to	what	was	
described	previously	[10,11,14,15,17,19,22],	and	there	was	a	trend	for	this	discrepancy	to	
increase	with	increasing	steatosis	severity.	The	revised	mFPA	classification	used	herein	matches	
the	conventional	pathology	grading	system	and	adjusts	for	systematic	disparities	between	
measured	and	estimated	fat	percentage	areas.	Agreement	with	pathologists	was	high,	and	the	
scale	was	accurate	in	differentiating	low-	and	high-grade	steatosis.	Besides,	DIA	images	can	be	
transferred	to	the	recipient	hospital	for	senior	surgical	review.	Digital	image	analysis	is	
accessible	to	most	pathologists	and	surgeons;	a	light	microscope	mounted	with	a	digital	camera	
is	available	in	most	hospitals	involved	in	liver	retrieval,	dedicated	software	for	image	analysis	
can	be	installed	on	a	personal	laptop,	and	steatosis	scoring	takes	10	to	15	minutes	to	complete	
after	uploading	the	images.	Despite	these	advantages,	it	is	crucial	to	note	that	DIA	cannot	replace	
standard	H&E	assessment	in	liver	transplantation	yet.	The	performance	of	DIA	should	be	
evaluated	using	frozen	tissue	biopsies,	similar	to	the	current	clinical	practice.	Furthermore,	the	
validity	of	the	revised	mFPA	scale	needs	to	be	analyzed	in	clinical	outcome	studies,	alongside	
clinical	and	pathologic	assessment	methods.	It	is	noteworthy	that	DIA	is	a	measurement	of	area	
and	cannot	replace	routine	histopathology	for	assessment	of	other	necroinflammatory	lesions	of	
steatohepatitis,	such	as	inflammation	and	hepatocyte	ballooning.	
	
Finally,	there	was	no	difference	in	steatosis	severity	between	2	distant	liver	segments,	suggesting	
that	1	liver	biopsy	is	sufficient	for	steatosis	assessment,	which	agrees	with	the	practice	of	the	
majority	of	UK	and	US	surgeons	[6].	This	is	noteworthy	as	biopsied	steatotic	livers	are	at	a	higher	
risk	of	hemorrhage	and	subcapsular	hematoma	following	reperfusion	[35].	
	
In	the	current	study,	pathologists	and	DIA	evaluated	the	same	slides	at	similar	magnification	
power,	and	raters	were	blinded	to	results	from	other	methods	to	reduce	bias.	We	used	specimens	
stained	with	H&E,	in	preference	to	fat-specific	stains,	because	it	is	commonly	used	in	surgical	
practice.	Standard	H&E	assessment	was	performed	by	2	experienced	pathologists	routinely	
involved	in	liver	assessment,	and	the	DIA	method	used	herein	was	previously	validated	and	
reported	in	previous	studies	from	our	center	[10,14].	A	possible	limitation	of	the	study	is	that	the	
high	level	of	agreement	between	the	2	pathologists	was	influenced	by	working	in	the	same	
institution,	despite	being	blinded	to	each	other.	It	is	unlikely	that	this	caused	bias,	as	high	
agreement	between	pathologists	from	different	centers	has	been	shown	in	previous	studies	
[10,14,25].	Another	limitation	of	the	study	is	the	lack	of	clinical	outcomes,	which	could	not	be	
assessed,	as	the	livers	were	discarded	and	nontransplantable	by	default.	Part	of	this	research	was	
performed	on	retrospective	data	from	organ	retrieval	forms,	and	6	livers	were	not	assigned	a	
specific	grade	indicating	a	degree	of	diagnostic	uncertainty.	
	
In	conclusion,	clinical	assessment	of	steatosis	is	inaccurate	and	could	increase	the	risk	of	
unnecessary	discard	of	livers.	While	DIA	is	feasible	and	more	accurate,	further	clinical	studies	are	
required	to	evaluate	its	validity.	
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